Bonesupport Hold

In my view, this is a future topic in surgery and orthopedics.

Moin together,

I am currently looking at Bonesupport Holding as a potential investment. I would be interested in your opinion.

Bonesupport Holding AB is a Swedish based orthobiology company. It develops and markets injectable bioceramic bone graft substitutes that remodel into host bone and are capable of eluting drugs directly into bone. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are designed to treat patients with fractures and bone gaps caused by trauma and related surgeries, as well as infections or diseases such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.

The company (86 employees) is still making a loss. However, with the business model, I can see this being a future market. Losses have been reduced from 2019 to 2020. The main sales markets are North America and Europe. Here it increased application within one year (from 2019 to 2020) by 46% in North America and by 6% in Europe.

This company comes from the biopharmaceutical industry and occupies a niche that I think is very relevant for the future.

I am looking forward to your opinions.